Varian Announces First Participant Treated in GENESIS II Clinical Trial of Genicular Artery Embolization for Knee Osteoarthritis PR Newswire PALO ALTO, Calif., Nov. 17, 2022 PALO ALTO, Calif...
Varian and the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center Announce Promising Results from FAST-01, First-in-Human Clinical Trial of Flash Therapy PR...
Icon Group First in World to Adopt New Multi-Disciplinary Oncology Information System from Varian PR Newswire PALO ALTO, Calif., Aug. 5, 2021 PALO ALTO, Calif., Aug. 5, 2021 /PRNewswire/...
Varian and Icon Group Partner to Extend Commitment to Global Cancer Care PR Newswire PALO ALTO, Calif., April 27, 2021 PALO ALTO, Calif., April 27, 2021 /PRNewswire/ -- Varian (NYSE: VAR), a...
PTC Set to Join S&P 500; Lattice Semiconductor & Progyny to Join S&P MidCap 400; Domtar to Join S&P SmallCap 600 PR Newswire NEW YORK, April 15, 2021 NEW YORK, April 15, 2021...
Varian Wins Best After-Sales Service Award for Radiotherapy Products in China for Fourth Consecutive Year PR Newswire PALO ALTO, Calif., April 12, 2021 PALO ALTO, Calif., April 12, 2021...
Varian and Google Cloud Collaborate to Aid in the Fight Against Cancer Company will work closely with Google Cloud and build AI tools for radiation oncology organ segmentation using the Google...
Varian Medical Systems Invests in Bend It Technologies, Ltd., a Company Developing Novel Steerable Microcatheters Patented technology provides interventionalists with 3D-controlled bending and...
Varian Announces CEO Succession Plan President and COO Chris Toth to Lead Varian as Part of Siemens Healthineers Dow Wilson to Retire as CEO; Will Serve as Special Advisor to the Combined...
CTSI Oncology Solutions, a Varian Company, to Provide Technology-Enabled Services for Radiation Oncology at CHRISTUS Health Multi-year agreement covers comprehensive services in support of...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales